NFA
ABBV icon

Nuveen Fund Advisors’s AbbVie ABBV Stock Holding History

Nuveen Fund Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,986
Closed -$555K – 120
2018
Q2 		$555K Sell
5,986
-9,509
-61% -$929K 0.68% 49
2018
Q1 		$1.47M Sell
15,495
-25,916
-63% -$2.85M 0.68% 39
2017
Q4 		$4M Sell
41,411
-19,146
-32% -$1.8M 1.16% 23
2017
Q3 		$5.38M Sell
60,557
-11,644
-16% -$886K 1.09% 18
2017
Q2 		$5.24M Sell
72,201
-392
-0.5% -$26.4K 0.84% 26
2017
Q1 		$4.73M Buy
72,593
+12,529
+21% +$788K 0.62% 34
2016
Q4 		$3.76M Buy
60,064
+9,327
+18% +$569K 0.54% 50
2016
Q3 		$3.2M Buy
50,737
+8,976
+21% +$581K 0.45% 62
2016
Q2 		$2.58M Buy
+41,761
New +$2.54M 0.4% 81

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nuveen Fund Advisors's ABBV Position: Q3 2018 in Review

Nuveen Fund Advisors sold out of AbbVie (ABBV) in Q3 2018, closing a stake of 5,986 shares — an estimated $555K sold.

Nuveen Fund Advisors first reported a position in ABBV in Q2 2016 and held it in 9 quarters. The position peaked at $5.38M in Q3 2017. 1,956 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

  • Nuveen Fund Advisors reported no remaining AbbVie position as of Q3 2018 after selling out during the quarter.
  • Nuveen Fund Advisors sold 5,986 AbbVie shares in Q3 2018, an estimated $555K.
  • Nuveen Fund Advisors first reported a position in AbbVie in Q2 2016 and held it in 9 quarters.
  • Nuveen Fund Advisors's AbbVie position peaked at $5.38M in Q3 2017.
  • 1,956 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Nuveen Fund Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.